Lucas W. Buchanan - May 20, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
May 20, 2022
Transactions value $
-$3,432,115
Form type
4
Date filed
8/12/2022, 08:45 PM
Previous filing
Mar 4, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $34K +7.18K +2.89% $4.73 256K Aug 10, 2022 Direct F1
transaction SILK Common Stock Sale -$338K -7.18K -2.81% $47.03 249K Aug 10, 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $34.1K +2.81K +1.13% $12.15 252K Aug 10, 2022 Direct F1
transaction SILK Common Stock Sale -$132K -2.81K -1.12% $47.03 249K Aug 10, 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $12.1K +2.56K +1.03% $4.73 251K Aug 10, 2022 Direct F1
transaction SILK Common Stock Sale -$121K -2.56K -1.02% $47.03 249K Aug 10, 2022 Direct F1, F2
transaction SILK Common Stock Options Exercise $59.7K +4.91K +1.98% $12.15 254K Aug 10, 2022 Direct F1
transaction SILK Common Stock Sale -$231K -4.91K -1.94% $47.03 249K Aug 10, 2022 Direct F1, F2
transaction SILK Common Stock Award $13.5K +550 +0.22% $24.51 249K May 20, 2022 Direct F3
transaction SILK Common Stock Sale -$354K -7.54K -3.02% $47.03 242K Aug 10, 2022 Direct F2, F4
transaction SILK Common Stock Sale -$1.22M -25K -10.34% $48.60 217K Aug 11, 2022 Direct F4, F5
transaction SILK Common Stock Sale -$1.19M -25K -11.53% $47.79 192K Aug 12, 2022 Direct F4, F6
holding SILK Common Stock 13.5K May 20, 2022 Buchanan Grandchildren's Irrevocable Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -7.18K -100% $0.00* 0 Aug 10, 2022 Common Stock 7.18K $4.73 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -2.81K -100% $0.00* 0 Aug 10, 2022 Common Stock 2.81K $12.15 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -2.56K -100% $0.00* 0 Aug 10, 2022 Common Stock 2.56K $4.73 Direct F1, F8
transaction SILK Option (right to buy) Options Exercise $0 -4.91K -100% $0.00* 0 Aug 10, 2022 Common Stock 4.91K $12.15 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
F2 This transaction was executed in multiple trades at price ranging from $46.15 to $48.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F4 The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
F5 This transaction was executed in multiple trades at price ranging from $47.38 to $49.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at price ranging from $47.29 to $48.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F8 All of the shares subject to this option are fully vested and exercisable as of the date hereof.